Inovio Pharmaceuticals (INO) Reports Q4 Loss, Tops Revenue Estimates
2/3 00:05
Inovio Pharmaceuticals (INO) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items....